Charitable trust registration requires a specified-violation notice; settled cash deposits and related-party payments did not justify cancellation or ...
External development charges trigger TDS under section 194C, while disputed administrative payments require factual verification and fresh adjudicatio...
Section 270AA penalty immunity requires identified statutory defaults and a hearing before rejection; reassessment disclosure may constitute under-rep...
Section 80JJAA employee-cost deduction allowed for deployed staff but barred against transfer-pricing income enhancement, with pricing issues remanded...
Transfer-pricing methodology protects commercially genuine associated-enterprise payments, while pre-2016 secondary adjustments and related notional i...
Negative liens over operating assets can constitute international transactions requiring arm's-length pricing reflecting restricted borrowing and expa...
Cross-examination rights in Customs Broker revocation inquiries require witness examination; procedural denial may be cured through fresh adjudication...
DGFT issued Trade Notice 06/2025-26 establishing a one-time quota allocation of 25,000 MT for Pharma Grade Sugar exports under restricted category for the current sugar season ending September 30, 2025. Applications must be submitted online through DGFT's ECOM system between June 20-July 20, 2025. Eligibility requires valid drug manufacturing license from State Licensing Authority and PHARMEXIL membership with valid RCMC. Quota allocation follows pro-rata basis based on production capacity. Export authorizations remain valid for one year with mandatory NABL-accredited laboratory certification confirming pharma grade specifications at export time. Only one application per IEC considered, with deficient or late applications rejected.
DGFT issued Trade Notice 06/2025-26 establishing a one-time quota allocation of 25,000 MT for Pharma Grade Sugar exports under restricted category for the current sugar season ending September 30, 2025. Applications must be submitted online through DGFT's ECOM system between June 20-July 20, 2025. Eligibility requires valid drug manufacturing license from State Licensing Authority and PHARMEXIL membership with valid RCMC. Quota allocation follows pro-rata basis based on production capacity. Export authorizations remain valid for one year with mandatory NABL-accredited laboratory certification confirming pharma grade specifications at export time. Only one application per IEC considered, with deficient or late applications rejected.
Note: It is a system-generated summary and is for quick reference only.